Hearing Aids and the Brain
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03279510 |
Recruitment Status :
Completed
First Posted : September 12, 2017
Last Update Posted : March 24, 2023
|
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Hearing Loss | Device: hearing aids | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 20 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Hearing Aids and the Brain |
Actual Study Start Date : | March 22, 2018 |
Actual Primary Completion Date : | January 31, 2021 |
Actual Study Completion Date : | January 31, 2021 |

Arm | Intervention/treatment |
---|---|
Experimental: Hearing aids
All study participants will be fit with hearing aids.
|
Device: hearing aids
Subjects are fit with hearing aids. |
- Evoked potential latency [ Time Frame: Approximately 1 year ]Latency will be measured in milliseconds
- Evoked potential amplitude [ Time Frame: Approximately 1 year ]Amplitude will be measured in microvolts
- Frequency following response magnitude [ Time Frame: Approximately 1 year ]Magnitude of response measured in nanovolts
- Frequency following response timing [ Time Frame: Approximately 1 year ]Timing measured by cross-correlation between stimulus and response
- Ongoing electroencephalography power [ Time Frame: Approximately 1 year ]EEG power as a function of frequency recorded during words-in-noise measure
- Montreal Cognitive Assessment score [ Time Frame: Approximately 1 year ]Assessment score from 1 to 30
- Reading Span [ Time Frame: Approximately 1 year ]Percent correct recall on working memory task
- Hearing aid usage [ Time Frame: Approximately 1 year ]Data logging from the hearing aid will provide usage in hours per day
- Word-in-noise perception testing [ Time Frame: Approximately 1 year ]Signal-to-noise ratio at which participant correctly understands 50% of speech in noise using WIN test
- Listening invested/required effort [ Time Frame: Approximately 1 year ]Participants' rating of the effort required (0-9) and invested (0-9) for listening task
- Working memory testing [ Time Frame: Approximately 1 year ]Performance on auditory working memory task
- Glasgow Hearing Aid Benefit Profile (GHABP) [ Time Frame: Approximately 1 year ]Participants rating on five-point scale their perceived initial (i.e., unaided) hearing disability, initial handicap, aided benefit, aided handicap, HA use and HA satisfaction in four listening situations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 50 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- 50 years of age or older
- Bilateral, mild to moderately severe hearing loss
- Inexperienced hearing aid users
Exclusion Criteria:
- Subject deciding that they do not wish to wear hearing aids as necessitated per study protocol
- Audiometric thresholds that suggest research stimuli would not be audible
- Conductive hearing loss and/or other significant ear or hearing problems
- Non-native English speakers
- Conditions or circumstances that would preclude a participant from wearing hearing aids consistently or finishing the study
- An inability to perform or complete the experimental tasks

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03279510
United States, Oregon | |
VA Portland Health Care System, Portland, OR | |
Portland, Oregon, United States, 97239 |
Principal Investigator: | Curtis J. Billings, PhD | VA Portland Health Care System, Portland, OR |
Responsible Party: | VA Office of Research and Development |
ClinicalTrials.gov Identifier: | NCT03279510 |
Other Study ID Numbers: |
C2396-P |
First Posted: | September 12, 2017 Key Record Dates |
Last Update Posted: | March 24, 2023 |
Last Verified: | March 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | Yes |
Product Manufactured in and Exported from the U.S.: | No |
auditory perception hearing |
Hearing Loss Hearing Disorders Ear Diseases Otorhinolaryngologic Diseases |
Sensation Disorders Neurologic Manifestations Nervous System Diseases |